Shares of AstraZeneca PLC AZN inched down 0.57% to £115.88 Monday, on what proved to be an all-around grim trading session ...

FDA has approved Tagrisso for the treatment of adult patients with locally advanced, unresectable NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

Among the investors in Aktis’ Series B round were Bristol Myers Squibb, Eli Lilly and Merck & Co., all of which have expanded their involvement in the radiopharma field.

Roche (OTCQX:RHHBY) said Monday that three obesity and diabetes drug candidates acquired through its takeover of Carmot ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

BridgeBio Pharma has been on the road to redemption ever since its treatment for a rare and fatal heart condition, acoramidis ...

The lawyer representing a family currently locked in a legal battle with the NHS over a bid to sedate a Down’s syndrome man ...

Brigham researchers have developed a nasal spray called PCANS that blocks a wide range of respiratory infections by trapping ...

Then, in mid-September, after receiving an offer for its shares from a moneyed group of institutional investors, Summit sold ...

In the U.K., a pharma-run watchdog has been issuing fines and levying suspensions. Could this help build public trust?

Former prime minister Boris Johnson considered launching an “aquatic raid” on a warehouse in the Netherlands to retrieve ...